Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Medicines in development for selected cancer types in the U.S. 2018
Medicines in development for selected cancer types in the United States as of 2018*
This statistic represents the medicines in development for selected cancer types in the United States as of May 2018. At this moment, 132 medicines for lung cancer were in development. Thus, lung cancer was the type of cancer with one of the largest numbers of drugs in development.
Medicines in development for selected cancer types in the United States as of 2018*
| Cancer type | Number of medicines in development |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Cancer type | Number of medicines in development |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- May 2018
- Region
- United States
- Survey time period
- as of May 2018
- Special properties
- PhRMA members
- Supplementary notes
- * Some medicines are being explored in more than one therapeutic category.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- May 2018
More information
- Region
- United States
- Survey time period
- as of May 2018
- Special properties
- PhRMA members
- Supplementary notes
- * Some medicines are being explored in more than one therapeutic category.
- Open this statistic in...
Other statistics on the topic
Breast cancer in the U.S.
+State of Health
Deaths by breast cancer in the U.S. 1950-2016
+Physicians, Hospitals & Pharmacies
Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017
+Physicians, Hospitals & Pharmacies
Average inpatient and outpatient cases per hospital in the U.S. by disease 2017
+State of Health
Cancer: 5-year survival rates in the U.S. 2008-2014
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate solution including all features.
Prices do not include sales tax.
All Information
in one Presentation
- 81 page/s
- English
- pptx
- Detailed references
Everything On "Breast cancer in the U.S." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
- Overview
- Percentage of U.S. adults who believed they were most likely to survive select cancers if diagnosed as of 2017Leading beliefs about the most survivable cancers in the U.S. as of 2017
- Estimated number of new cancer cases among women in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among women 2009 and 2019
- Number of female cancer survivors in the U.S. as of January 1, 2019, by site*Number of U.S. female cancer survivors as of 2019, by site
- Age-specific 10-year probability of developing invasive breast cancer for women in the U.S. as of 201910-year probability of developing invasive breast cancer in females U.S. 2019, by age
- Percentage of patients whose tumors are driven by certain genetic mutations as of 2016, by cancer typePatients whose tumors are driven by genetic mutations by cancer type 2016
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2017*Average inpatient and outpatient cases per hospital in the U.S. by disease 2017
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2017 (in U.S. dollars)*Charges for inpatients in U.S. hospitals per case by condition 2017
- Incidence
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)United States: incidence rates for cancer 2011-2015, by gender
- Number of female breast cancer cases (in situ and invasive) in the U.S. as of 2019, by ageFemale breast cancer cases U.S. 2019, by age
- Female breast cancer incidence rate in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)Female breast cancer incidence rate U.S. 2012-2016, by ethnicity
- Number of new breast cancer cases in the U.S. in 2016, by state (per 100,000 population)Breast cancer incidence rate in the U.S. in 2016, by state
- Rate of overweight and obesity-related invasive cancer cases in the United States in 2014, by cancer type (per 100,000 population)Rate of overweight and obesity-related cancer cases U.S. 2014, by cancer type
- Deaths
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)U.S. death rates from cancer by type and gender 2012-2016
- Estimated number of cancer deaths among women in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among women 2009 and 2019
- Deaths by breast cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by breast cancer in the U.S. 1950-2016
- Number of breast cancer deaths in the United States from 1999 to 2015, by genderNumber of breast cancer deaths in U.S. 1999-2015, by gender
- Number of female deaths due to breast cancer in the U.S. as of 2019, by ageFemale deaths due to breast cancer U.S. 2019, by age
- Female breast cancer mortality rate in the U.S. from 2013 to 2017, by ethnicity (per 100,000 population)Female breast cancer mortality rate U.S. 2013-2017, by ethnicity
- Number of breast cancer deaths in the U.S. in 2016, by state (per 100,000 population)Breast cancer death rate in the U.S. in 2016, by state
- Treatment
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancerCancer: 5-year survival rates in the U.S. 2008-2014
- Five-year breast cancer specific survival rates in the U.S. from 2009 to 2015, by ethnicityFive-year breast cancer specific survival rates U.S. 2009-2015, by ethnicity
- Distribution of treatment types for female breast cancer in the U.S. in 2016, by stageDistribution of treatment types for female breast cancer by stage 2016
- Rate of mastectomy among adult females in the United States from 2009 to 2014 (per 100,000 females)*Adult female mastectomy rate in U.S. 2009-2014
- Rate of mastectomy among adult females in the United States in 2009 and 2014, by age group (per 100,000 females)Adult female mastectomy rate in U.S. 2009 and 2014, by age group
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2017 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017
- Medicines in development for selected cancer types in the United States as of 2018*Medicines in development for selected cancer types in the U.S. 2018
- Percentage of U.S. female breast cancer patients and survivors whose jobs were impacted by their breast cancer treatment as of 2017Career impacts of breast cancer treatments on U.S. survivors and patients as of 2017
- Prevention
- Percentage of U.S. women that reported having a mammogram within the past 2 years from 2001 to 2017U.S. women that reported having a mammogram from 2001-2017
- Percentage of U.S. women aged 50-74 years who received a mammogram as of 2015, by ethnicity*Percentage of US women who have received a mammogram by ethnicity 2015
- Percentage of U.S. women who had received a breast cancer screening as of 2015, by health care coverage*US women who received a mammogram by health care coverage 2015
- Percentage of U.S. women who had received a breast cancer screening as of 2015, by education level*US women who received a mammogram by education level 2015
- Percentage of U.S. women aged 40 years and older that reported having a mammogram within the past 2 years from 2014 to 2016, by stateU.S. women that have had a mammogram within the past 2 years from 2014-2016, by state
- Cancer conditions in Spain 2018, by gender and age
- Cancer conditions in Spain 2018, by age group
- Cancer specialist input into MCO coverage policy development in U.S. 2018
- Oncology therapeutic spending growth 2013-2018 U.S. vs pharmerging
- Top hospitals for adult cancer in the U.S. 2019
- Number of doctors in top hospitals for adult cancer in the U.S. 2016
- Visits to chemotherapy daycare in French healthcare facilities 2015
- Europe: value of selected medical markets 2015 and 2022
- Latin America: oncology information system revenue 2018-2023
- Total cancer funding by National Institutes for Health 2013-2020
- Quality of treatment option information for cancer patients and caregivers 2015
- Quality of diagnosis information for cancer patients and caregivers 2015
- People affected by cancer in France 2015, by type and gender
- Number of deaths due to cancer by gender Spain 2000-2015
- Number of new cases of cancer by gender in Spain 2017
- Monthly value of medicament exports from Norway 2017-2018
- Opinion: farm animals should be treated with antibiotics if necessary Austria 2018
- Monthly value of medicament exports from Finland 2018
- Domestic sales value of biological product in Taiwan 2008-2017
- Incidents of substandard medicines in Canada by defect type 2005-2013
- Oncology
- Personalized medicine
- Patented Medicine Prices Review Board - Annual Report 2017
- Prescribing for Diabetes, England 2007/08 to 2017/18
- Prescription Cost Analysis, England 2018
- Patented Medicine Prices Review Board - Annual Report 2016
- CDER New Drugs Program: 2018 Update
- CDER 2018 New Drug Therapy Approvals
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical trends in Europe
- CDER 2017 New Drug Therapy Approvals
- CDER New Drugs Program: 2017 Update
- 2014 Regional Report - Complementary Medicines in Australia
- Complementary Medicines Australia 2017/18 Federal pre-Budget Submission
- Prescription Cost Analysis, England 2014
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.